Vimarsana
Biggest News Aggregation in the World

Page 7 - Auto Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Auto Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Auto Immune Today - Breaking & Trending Today

COVID can make the body attack itself. Medical imaging shows the results. - Vimarsana News

COVID can make the body attack itself. Medical imaging shows the results.

COVID can make the body attack itself. Medical imaging shows the results. With the help of medical imaging, a new study is illustrating for the first time some of the rare consequences of COVID-19: how the disease can trick the body into attacking its own muscles, joints and nerves. and last updated 2021-03-01 11:06:22-05 SAN DIEGO (KGTV) -- With the help of medical imaging, a new study is illustrating for the first time some of the rare consequences of COVID-19: how the disease can trick the body into attacking its own muscles, joints and nerves. The study, published in the journal

Source: 10news.com
Jubilant Therapeutics Announces Research Collaboration with Boston Children's Hospital, Harvard Medical School, to Evaluate PAD4 Inhibitors in Autoimmune/Inflammation Disease Models - Vimarsana News

Jubilant Therapeutics Announces Research Collaboration with Boston Children's Hospital, Harvard Medical School, to Evaluate PAD4 Inhibitors in Autoimmune/Inflammation Disease Models

(1) BEDMINSTER, N.J., Feb. 25, 2021 /PRNewswire/ -- Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced a collaboration with Boston Children's Hospital (https://wistar.org/) to evaluate peptidyl arginine deiminase 4 (PAD4) inhibitors under development by Jubilant Therapeutics to explore the modulation of neutrophil extracellular traps (NETosis) in preclinical models of neutrophil regulation and rheumatoid arthritis (RA). PAD4 is an enzyme that converts arginine to citru...

Eli lilly to pay up to $960 million for Rigel's autoimmune disease therapy - Vimarsana News

Eli lilly to pay up to $960 million for Rigel's autoimmune disease therapy

Rigel will receive an upfront cash payment of $125 million, with the potential for an additional up to $835 million in milestone payments. R552 belongs to a class of drugs called RIPK1 inhibitors which target a critical signaling protein that regulates inflammation and cell death in tissues. It is a new approach to treat various autoimmune, inflammatory, and neurodegenerative disorders.

Source: yahoo.com
Boston COVID-19 Patient May Provide Clues to Variants Origins - Vimarsana News

Boston COVID-19 Patient May Provide Clues to Variants Origins

The case, detailed in The New England Journal of Medicine, has drawn the attention of professionals researching the SARS-CoV-2 virus that causes COVID-19. They believe it may lead to the origin of the variants of the disease that have emerged, such as those from South Africa and Britain, New York Fox network affiliate WNYW said on its website.

Mom's Autoimmune Disease Linked to Child's ADHD - Vimarsana News

Mom's Autoimmune Disease Linked to Child's ADHD

Conditions Feb 2, 2021 03:41 PM By Sabrina Emms A new study links autoimmune disease in an expectant mother with the increased chance of her child having ADHD. Photo courtesy of Shutterstock Parents pass all kinds of things down to their kids -  red hair, bad eyesight, maybe even a taste for spicy food. Sometimes, the health conditions of a parent can make an impact on the child. This is the case with autoimmune disorders in mothers, and ADHD in their children. New research, published in JAMA Pediatrics, explored the connection.  Typically, when we think of parents passing thi...